Please login to the form below

Not currently logged in
Email:
Password:

clazakizumab

This page shows the latest clazakizumab news and features for those working in and with pharma, biotech and healthcare.

Sanofi's sarilumab beats Humira in head-to-head trial

Sanofi's sarilumab beats Humira in head-to-head trial

Other companies developing IL-6 inhibitors for RA include GlaxoSmithKline (GSK) and Janssen, whose sirukumab candidate is scheduled for filing later this year, and Alder Bio Pharmaceuticals which has clazakizumab in

Latest news

  • Positive data for BMS’ clazakizumab in arthritis Positive data for BMS’ clazakizumab in arthritis

    Positive data for BMS’ clazakizumab in arthritis. Phase II results indicate drug is as effective as AbbVie’ s Humira. ... Clazakizumab … provides promising remission data that will need to be further investigated," he added.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics